BioSpace News Archive

The U.S. FDA issued a new template for clinical test developers that is designed to assist these companies in developing and submitting emergency use authorization (EUA) for COVID-19 tests that can be performed at home or in other settings besides laboratories.

This morning Johnson & Johnson announced preclinical data that showed its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19.

The vaccine was developed by Preston Estep, a former graduate student of Harvard University geneticist George Church.

As the world continues to navigate through the coronavirus pandemic, many biopharma companies are surging ahead with job creations. Check out these companies that have made recent job expansion announcements.

Roche is first company to offer molecular labs complete end-to-end automation solution for testing consolidation

Tiziana Life Sciences plc announced that Kunwar Shailubhai, Ph.D., the Company’s CEO and CSO, will share insight into Tiziana’s development pipeline and upcoming milestones during an investor webinar, hosted by RedChip Companies, on Thursday, July 30, 2020 at 4:00 p.m. U.S. Eastern.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its audited financial results for the three and six months ended June 30, 2020 on Friday, August 14, 2020 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m.

Japan Business Venture shifts focus to specialty assets and a portfolio of select generics that meet patients’ medical needs

Indivior PLC announced that its first half and second quarter 2020 results press release is now available via the London Stock Exchange’s Regulatory News Service and on the “Investors” section of the company’s website at www.indivior.com.

Moberg Pharma AB announces the appointment of Dr Cindy Wong as Chief Medical Officer of Moberg Pharma. Dr Wong will during the fall be joining the management team at Moberg Pharma coming from a previous position as Vice President and Head of Global Clinical Development at Metz Pharmaceuticals GmbH.